SE8004002L
(sv)
|
1980-05-29 |
1981-11-30 |
Arvidsson Folke Lars Erik |
Terapeutiskt anvendbara tetralinderivat
|
EP0091241B1
(en)
|
1982-04-02 |
1988-12-28 |
Takeda Chemical Industries, Ltd. |
Condensed pyrrolinone derivatives, and their production
|
US4789678A
(en)
|
1986-08-25 |
1988-12-06 |
Hoechst-Roussel Pharmaceuticals, Inc. |
Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds
|
US4927838A
(en)
|
1987-07-10 |
1990-05-22 |
Hoffman-La Roche Inc. |
Pyridine compounds which are useful in treating a disease state characterized by an excess of platelet activating factors
|
CA1327795C
(en)
|
1987-08-14 |
1994-03-15 |
Jules Freedman |
Antidepressants which are aryloxy inadanamines
|
US5300523A
(en)
|
1988-07-28 |
1994-04-05 |
Bayer Aktiengesellschaft |
Substituted aminomethyltetralins and their heterocyclic analogues
|
DE3901814A1
(de)
|
1988-07-28 |
1990-02-01 |
Bayer Ag |
Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
|
US5545755A
(en)
|
1989-05-31 |
1996-08-13 |
The Upjohn Company |
Therapeutically useful 2-aminotetralin derivatives
|
DE69032725T2
(de)
|
1989-05-31 |
1999-04-08 |
Upjohn Co |
ZNS-wirksame 8-Heterocyclyl-2-aminotetralin Derivate
|
US5071875A
(en)
|
1989-09-25 |
1991-12-10 |
Northwestern University |
Substituted 2-amidotetralins as melatonin agonists and antagonists
|
KR100207876B1
(ko)
|
1990-10-12 |
1999-07-15 |
로버트 에이. 아미테이지 |
치료학적으로 유용한 2-아미노테트랄린 유도체
|
WO1992019234A2
(en)
|
1991-04-26 |
1992-11-12 |
The Upjohn Company |
Method of treating/preventing substance abuse using 1-alkyl-5(substituted oxy)-2-aminotetralins
|
JPH05213884A
(ja)
|
1991-06-14 |
1993-08-24 |
Upjohn Co:The |
新規な4−アミノキノリン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤
|
GB9127306D0
(en)
|
1991-12-23 |
1992-02-19 |
Boots Co Plc |
Therapeutic agents
|
MY115155A
(en)
|
1993-09-09 |
2003-04-30 |
Upjohn Co |
Substituted oxazine and thiazine oxazolidinone antimicrobials.
|
PT1019385E
(pt)
|
1995-09-15 |
2004-06-30 |
Upjohn Co |
N-oxidos de aminoaril-oxazolidinona
|
SK285854B6
(sk)
|
1996-05-31 |
2007-09-06 |
Allelix Neuroscience Inc. |
Substituovaný amín, spôsoby jeho prípravy a použitie, farmaceutický prostriedok a jeho použitie
|
US6083986A
(en)
|
1996-07-26 |
2000-07-04 |
Icagen, Inc. |
Potassium channel inhibitors
|
US6057357A
(en)
|
1997-04-30 |
2000-05-02 |
Warner-Lambert Company |
Peripherally selective kappa opioid agonists
|
WO1998056757A1
(fr)
|
1997-06-11 |
1998-12-17 |
Sankyo Company, Limited |
Derives de benzylamine
|
US20030220234A1
(en)
|
1998-11-02 |
2003-11-27 |
Selvaraj Naicker |
Deuterated cyclosporine analogs and their use as immunodulating agents
|
TW555757B
(en)
|
1998-07-31 |
2003-10-01 |
Akzo Nobel Nv |
Aminomethylcarboxylic acid derivatives
|
EP1119543B1
(en)
|
1998-10-07 |
2004-12-15 |
Ortho-McNeil Pharmaceutical, Inc. |
N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor
|
EP1199306B1
(en)
|
1999-07-26 |
2005-12-07 |
Banyu Pharmaceutical Co., Ltd. |
Biarylurea derivatives
|
AR030676A1
(es)
|
1999-07-28 |
2003-09-03 |
Ortho Mcneil Pharm Inc |
Derivados de aminas y amidas como ligandos para el receptor del neuropeptido y y5 utiles en el tratamiento de la obesidad y otros trastornos, uso de los mismos para la elaboracion de medicamentos y composiciones farmaceuticas que los comprenden
|
GB9918037D0
(en)
|
1999-07-30 |
1999-09-29 |
Biochemie Gmbh |
Organic compounds
|
US6426364B1
(en)
|
1999-11-01 |
2002-07-30 |
Nps Allelix Corp. |
Diaryl-enynes
|
JP4850332B2
(ja)
|
2000-10-18 |
2012-01-11 |
東京エレクトロン株式会社 |
デュアルダマシン構造のエッチング方法
|
JP2004529132A
(ja)
|
2001-03-27 |
2004-09-24 |
アクテリオン ファマシューティカルズ リミテッド |
1,2,3,4−テトラヒドロイソキノリン誘導体
|
AU2756602A
(en)
|
2001-04-25 |
2002-10-31 |
Pfizer Products Inc. |
Methods and kits for treating depression or preventing deterioration of cognitive function
|
US6831193B2
(en)
|
2001-05-18 |
2004-12-14 |
Abbott Laboratories |
Trisubstituted-N-[(1S)-1,2,3,4-Tetrahydro-1-naphthalenyl]benzamides which inhibit P2X3 and P2X2/3 containing receptors
|
DE60206454T2
(de)
|
2001-08-16 |
2006-06-29 |
Pfizer Products Inc., Groton |
Difluormethylen aromatische Ether und ihre Verwendung als Inhibitoren des Glycin-Typ-1-Transporters
|
DE10149370A1
(de)
|
2001-10-06 |
2003-04-10 |
Merck Patent Gmbh |
Pyrazolderivate
|
CA2467870A1
(en)
|
2001-11-21 |
2003-06-05 |
Pharmacia & Upjohn Company |
Substituted aryl 1,4-pyrazine derivatives
|
JP2005513128A
(ja)
|
2001-12-20 |
2005-05-12 |
ハー・ルンドベック・アクチエゼルスカベット |
アリールオキシフェニル及びアリールスルファニルフェニル誘導体
|
GB0130696D0
(en)
|
2001-12-21 |
2002-02-06 |
Smithkline Beecham Plc |
Chemical Compounds
|
DE10210779A1
(de)
|
2002-03-12 |
2003-10-09 |
Merck Patent Gmbh |
Cyclische Amide
|
DE10217006A1
(de)
|
2002-04-16 |
2003-11-06 |
Merck Patent Gmbh |
Substituierte Indole
|
FR2838739B1
(fr)
|
2002-04-19 |
2004-05-28 |
Sanofi Synthelabo |
Derives de n-[phenyl(piperidin-2-yl)methyl)benzamide, leur preparation et leur application en therapeutique
|
WO2003097586A1
(en)
|
2002-05-17 |
2003-11-27 |
Janssen Pharmaceutica N.V. |
Aminotetralin-derived urea modulators of vanilloid vr1 receptor
|
ATE451369T1
(de)
|
2002-07-15 |
2009-12-15 |
Merck & Co Inc |
Piperidinopyrimidindipeptidylpeptidaseinhibitor n zur behandlung von diabetes
|
FR2842805A1
(fr)
|
2002-07-29 |
2004-01-30 |
Sanofi Synthelabo |
Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide,leur preparation et leur application et therapeutique
|
FR2842804B1
(fr)
|
2002-07-29 |
2004-09-03 |
Sanofi Synthelabo |
Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
|
US20040152741A1
(en)
|
2002-09-09 |
2004-08-05 |
Nps Allelix Corporation |
Arylglycine derivatives and their use as glycine transport inhibitors
|
US7084154B2
(en)
|
2003-02-11 |
2006-08-01 |
Pharmacopeia Drug Disclovery, Inc. |
2-(aminomethyl) arylamide analgesics
|
WO2004072034A1
(en)
|
2003-02-17 |
2004-08-26 |
F. Hoffmann-La Roche Ag |
Piperidine-benzenesulfonamide derivatives
|
ES2294475T3
(es)
|
2003-03-07 |
2008-04-01 |
Eli Lilly And Company |
Derivados de nicotinamida g-sustituidos como antagonistas de receptores de opioides.
|
DE10315570A1
(de)
|
2003-04-05 |
2004-10-14 |
Merck Patent Gmbh |
Triazolderivate
|
BRPI0409739A
(pt)
|
2003-04-30 |
2006-05-09 |
Lundbeck & Co As H |
composto, composição farmacêutica, uso de composto, e, método para o tratamento de uma doença ou de um distúrbio
|
JP2004359633A
(ja)
|
2003-06-06 |
2004-12-24 |
Bayer Cropscience Ag |
イソインドリノン誘導体の殺虫剤としての利用
|
GB0314478D0
(en)
|
2003-06-20 |
2003-07-23 |
Glaxo Group Ltd |
Compounds
|
GB0314479D0
(en)
|
2003-06-20 |
2003-07-23 |
Glaxo Group Ltd |
Compounds
|
GB0314476D0
(en)
|
2003-06-20 |
2003-07-23 |
Glaxo Group Ltd |
Compounds
|
ES2297458T3
(es)
|
2003-08-11 |
2008-05-01 |
F. Hoffmann-La Roche Ag |
Piperazina con grupo fenilo or-sustituido y su empleo como inhibidores de glyti.
|
CA2537292C
(en)
|
2003-09-09 |
2013-04-02 |
F. Hoffmann-La Roche Ag |
1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
|
DE602004020674D1
(de)
|
2003-09-09 |
2009-05-28 |
Hoffmann La Roche |
1-benzoyl-piperazin-derivate als glycin-aufnahmehemmer zur behandlung von psychosen
|
FR2861076B1
(fr)
|
2003-10-17 |
2006-01-06 |
Sanofi Synthelabo |
Derives de n-heterocyclymethylbenzamide, leur preparation et leur application en therapeutique
|
FR2861070B1
(fr)
|
2003-10-17 |
2006-01-06 |
Sanofi Synthelabo |
Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide et n-[(azepan-2-yl)phenylmethyl]benzamide, leur preparation et leur application en therapeutique
|
FR2861071B1
(fr)
|
2003-10-17 |
2006-01-06 |
Sanofi Synthelabo |
Derives de n-[phenyl(alkylpiperidin-2-yl) methyl]benzamide, leur prepartation et leur application en therapeutique
|
FR2861074B1
(fr)
|
2003-10-17 |
2006-04-07 |
Sanofi Synthelabo |
Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
|
FR2861073B1
(fr)
|
2003-10-17 |
2006-01-06 |
Sanofi Synthelabo |
Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
|
WO2005040166A1
(en)
|
2003-10-23 |
2005-05-06 |
F.Hoffmann-La Roche Ag |
Triaza-spiropiperidine derivatives for use as glyt-1 inhibitors in the treatment of neurological and neuropsychiatric disorders
|
WO2005046601A2
(en)
|
2003-11-12 |
2005-05-26 |
Merck & Co., Inc. |
4-phenyl piperdine sulfonyl glycine transporter inhibitors
|
GB0326840D0
(en)
|
2003-11-18 |
2003-12-24 |
Glaxo Group Ltd |
Compounds
|
GB0329362D0
(en)
|
2003-12-18 |
2004-01-21 |
Glaxo Group Ltd |
Compounds
|
WO2005058317A1
(en)
|
2003-12-18 |
2005-06-30 |
Glaxo Group Limited |
Glycine transporter-1 inhibirors
|
WO2005058885A2
(en)
|
2003-12-18 |
2005-06-30 |
Glaxo Group Limited |
Piperidine derivatives and their use as glycine transporter inhibitors
|
PL1737850T3
(pl)
|
2004-04-19 |
2008-02-29 |
Symed Labs Ltd |
Nowy sposób wytwarzania linezolidu i związków pokrewnych
|
DE102004030099A1
(de)
|
2004-06-22 |
2006-01-12 |
Grünenthal GmbH |
Gesättigte und ungesättigte 3-Pyridyl-benzocycloalkylmethyl-amine als Serotonin- und/oder Noradrenalin-Reuptake-Hemmer und/oder µ-Opioidrezeptor-Modulatoren
|
WO2006008754A1
(en)
|
2004-07-20 |
2006-01-26 |
Symed Labs Limited |
Novel intermediates for linezolid and related compounds
|
CN101036158A
(zh)
|
2004-08-31 |
2007-09-12 |
松下电器产业株式会社 |
内容购买处理终端和其方法及程序
|
US20060074105A1
(en)
|
2004-09-20 |
2006-04-06 |
Serenex, Inc. |
Substituted quinoline and quinazoline inhibitors of quinone reductase 2
|
US7511013B2
(en)
|
2004-09-29 |
2009-03-31 |
Amr Technology, Inc. |
Cyclosporin analogues and their pharmaceutical uses
|
RU2007121768A
(ru)
|
2004-12-15 |
2009-01-27 |
Ф. Хоффманн-Ля Рош Аг (Ch) |
Би- и трициклически замещенные фенилметаноны в качестве ингибиторов переносчика глицина 1 (glyt-1) для лечения болезни альцгеймера
|
JP4647670B2
(ja)
|
2005-02-07 |
2011-03-09 |
エフ.ホフマン−ラ ロシュ アーゲー |
グリシントランスポーター1の阻害剤としてのヘテロシクリル置換フェニルメタノン
|
WO2006102760A1
(en)
|
2005-04-01 |
2006-10-05 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
WO2006121767A2
(en)
|
2005-05-06 |
2006-11-16 |
Apath, Llc |
4-aminoquinoline compounds for treating virus-related conditions
|
TW200716636A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Heterocyclic spiro-compounds
|
US7956050B2
(en)
|
2005-07-15 |
2011-06-07 |
Albany Molecular Research, Inc. |
Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
|
US7514068B2
(en)
|
2005-09-14 |
2009-04-07 |
Concert Pharmaceuticals Inc. |
Biphenyl-pyrazolecarboxamide compounds
|
EP1957458A2
(en)
|
2005-12-01 |
2008-08-20 |
Elan Pharmaceuticals Inc. |
5-(arylsulfonyl)-pyrazolopiperidines
|
EP2032566A4
(en)
|
2006-06-12 |
2009-07-08 |
Merck Frosst Canada Ltd |
AZETIDINE DERIVATIVES AS DELTA-9 DEATURASE STÉAROYL-COENZYME INHIBITORS
|
GB0619176D0
(en)
|
2006-09-29 |
2006-11-08 |
Lectus Therapeutics Ltd |
Ion channel modulators & uses thereof
|
US8796267B2
(en)
|
2006-10-23 |
2014-08-05 |
Concert Pharmaceuticals, Inc. |
Oxazolidinone derivatives and methods of use
|
CN101616902B
(zh)
|
2007-02-15 |
2013-03-27 |
弗·哈夫曼-拉罗切有限公司 |
作为taar1配体的2-氨基*唑啉类化合物
|
BRPI0810362A2
(pt)
|
2007-04-19 |
2014-10-29 |
Concert Pharmaceuticals Inc |
Compostos de morfolinila deuterados
|
US7531685B2
(en)
|
2007-06-01 |
2009-05-12 |
Protia, Llc |
Deuterium-enriched oxybutynin
|
ATE551328T1
(de)
|
2007-06-06 |
2012-04-15 |
Dsm Sinochem Pharm Nl Bv |
Neuartige 5-substituierte hydantoine
|
MX2009014235A
(es)
|
2007-08-22 |
2010-04-27 |
Abbott Gmbh & Co Kg |
4-bencilaminoquinolonas, composiciones farmaceuticas que las contiene y su uso.
|
WO2009035598A1
(en)
|
2007-09-10 |
2009-03-19 |
Concert Pharmaceuticals, Inc. |
Deuterated pirfenidone
|
US20090118238A1
(en)
|
2007-09-17 |
2009-05-07 |
Protia, Llc |
Deuterium-enriched alendronate
|
US20090088416A1
(en)
|
2007-09-26 |
2009-04-02 |
Protia, Llc |
Deuterium-enriched lapaquistat
|
US20090082471A1
(en)
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched fingolimod
|
JP2010540635A
(ja)
|
2007-10-02 |
2010-12-24 |
コンサート ファーマシューティカルズ インコーポレイテッド |
ピリミジンジオン誘導体
|
US20090105338A1
(en)
|
2007-10-18 |
2009-04-23 |
Protia, Llc |
Deuterium-enriched gabexate mesylate
|
EP2212298B1
(en)
|
2007-10-18 |
2013-03-27 |
Concert Pharmaceuticals Inc. |
Deuterated etravirine
|
WO2009055006A1
(en)
|
2007-10-26 |
2009-04-30 |
Concert Pharmaceuticals, Inc. |
Deuterated darunavir
|
JP5554319B2
(ja)
|
2008-04-01 |
2014-07-23 |
アボット ゲーエムベーハー ウント カンパニー カーゲー |
テトラヒドロイソキノリン類、それを含む医薬組成物および治療におけるそれの使用
|
WO2010020548A1
(en)
|
2008-08-20 |
2010-02-25 |
F. Hoffmann-La Roche Ag |
Glyt1 receptor antagonists
|
US8822449B2
(en)
*
|
2008-09-02 |
2014-09-02 |
Sanofi |
Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
|
AR075442A1
(es)
|
2009-02-16 |
2011-03-30 |
Abbott Gmbh & Co Kg |
Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
|
TW201038569A
(en)
|
2009-02-16 |
2010-11-01 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
|
EP2246331A1
(en)
|
2009-04-24 |
2010-11-03 |
Westfälische Wilhelms-Universität Münster |
NR2B-selective NMDA-receptor antagonists
|
WO2010138901A1
(en)
|
2009-05-29 |
2010-12-02 |
Biogen Idec Ma Inc |
Carboxylic acid-containing compounds, derivatives thereof, and related methods of use
|
US8877794B2
(en)
|
2010-08-13 |
2014-11-04 |
Abbott Laboratories |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8846743B2
(en)
|
2010-08-13 |
2014-09-30 |
Abbott Laboratories |
Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9045459B2
(en)
|
2010-08-13 |
2015-06-02 |
AbbVie Deutschland GmbH & Co. KG |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8883839B2
(en)
|
2010-08-13 |
2014-11-11 |
Abbott Laboratories |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9051280B2
(en)
|
2010-08-13 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9309200B2
(en)
|
2011-05-12 |
2016-04-12 |
AbbVie Deutschland GmbH & Co. KG |
Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
EP2739614B1
(en)
|
2011-08-05 |
2017-02-22 |
AbbVie Deutschland GmbH & Co KG |
AMINOCHROMANEs, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY
|
US9365512B2
(en)
|
2012-02-13 |
2016-06-14 |
AbbVie Deutschland GmbH & Co. KG |
Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|